BackVicore Pharma Holding AB Overview

Vicore Pharma Holding AB Receivables

Latest receivables for VCRE: $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Vicore Pharma Holding AB Receivables History

Loading

Vicore Pharma Holding AB vs. peers: Receivables Comparison

Loading

Vicore Pharma Holding AB Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Vicore Pharma Holding AB (VCRE) FAQ

As of the most recent data (September 2026), VCRE shows a receivables of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VCRE's receivables is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Vicore Pharma Holding AB is outperforming or lagging.

Tracking VCRE's receivables over time shows whether Vicore Pharma Holding AB is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Vicore Pharma Holding AB's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.

Vicore Pharma Holding AB's receivables is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.